NEO R&D to Revenue
Neogenomics Inc · R&D to Revenue
NEO R&D to Revenue
Latest reported5.34%period ending
NEO Quarterly R&D/Revenue (0.00% → 5.34%)
Latest values, visible window
High-resolution chart · PNG
NEO r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 5.3363% | |
| 5.1074% | |
| 4.8267% | |
| 4.6295% | |
| 4.976% | |
| 6.0589% | |
| 4.6331% | |
| 4.5786% | |
| 4.7939% | |
| 4.8771% | |
| 4.5817% | |
| 3.478% | |
| 5.1063% | |
| 5.3892% | |
| 4.8124% | |
| 5.6778% | |
| 10.3348% | |
| 10.7648% | |
| 6.7708% | |
| 6.106% | |
| 2.8712% | |
| 2.1258% | |
| 1.6667% | |
| 1.5656% | |
| 2.4202% | |
| 1.9428% | |
| 1.9463% | |
| 2.4945% | |
| 2.5434% | |
| 1.2649% | |
| 0.6878% | |
| 0.6455% | |
| 1.5839% | |
| 1.5073% | |
| 0.8202% | |
| 2.0142% | |
| 1.5209% | |
| 1.3976% | |
| 1.5374% | |
| 1.5915% | |
| 2.0688% | |
| 2.4219% | |
| 6.8038% | |
| 3.4665% | |
| 3.295% | |
| 2.9054% | |
| 1.656% | |
| 4.3675% | |
| 3.0624% | |
| 3.454% | |
| 3.542% | |
| 2.0137% | |
| 3.948% | |
| 5.3331% | |
| 3.0079% | |
| 5.6893% | |
| 3.3822% | |
| 3.2784% | |
| 0% | |
| 1.1042% | |
| 1.6434% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 11.6504% | |
| 21.3938% | |
| 54.749% | |
| 208.9109% | |
| 0% | |
| 0% | |
| 0% |